FASLODEX is a Intramuscular Injection in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Fulvestrant.
| Product ID | 0310-0720_185e8383-2af3-4ddc-bef9-3ea4351ddbbd |
| NDC | 0310-0720 |
| Product Type | Human Prescription Drug |
| Proprietary Name | FASLODEX |
| Generic Name | Fulvestrant |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2010-11-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021344 |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | FULVESTRANT |
| Active Ingredient Strength | 50 mg/mL |
| Pharm Classes | Estrogen Receptor Antagonist [EPC],Estrogen Receptor Antagonists [MoA],Selective Estrogen Receptor Modulators [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2010-11-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021344 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-11-01 |
| Marketing Category | NDA |
| Application Number | NDA021344 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2002-05-20 |
| Marketing End Date | 2015-10-31 |
| Marketing Category | NDA |
| Application Number | NDA021344 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-11-01 |
| Marketing End Date | 2010-09-21 |
| Ingredient | Strength |
|---|---|
| FULVESTRANT | 50 mg/mL |
| SPL SET ID: | 83d7a440-e904-4e36-afb5-cb02b1c919f7 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0310-0720 | FASLODEX | Fulvestrant |
| 0143-9022 | Fulvestrant | Fulvestrant |
| 0310-7720 | Fulvestrant | Fulvestrant |
| 0591-5019 | Fulvestrant | Fulvestrant |
| 0781-3079 | Fulvestrant | Fulvestrant |
| 0781-3492 | Fulvestrant | Fulvestrant |
| 16714-070 | FULVESTRANT | fulvestrant |
| 16714-118 | Fulvestrant | Fulvestrant |
| 16729-436 | FULVESTRANT | Fulvestrant |
| 25021-462 | fulvestrant | fulvestrant |
| 43598-262 | Fulvestrant | Fulvestrant |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FASLODEX 75934871 2914736 Dead/Cancelled |
AstraZeneca (UK) Limited 2000-03-03 |
![]() FASLODEX 75934339 2886805 Dead/Cancelled |
AstraZeneca (UK) Limited 2000-03-03 |
![]() FASLODEX 75426734 2303455 Live/Registered |
ASTRAZENECA UK LIMITED 1998-01-30 |
![]() FASLODEX 74121720 1749766 Live/Registered |
AstraZeneca UK Limited 1990-12-10 |